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Many of the spectrophotometric techniques used to determine the properties of
intracellular human hemoglobin cannot be utilized due to the turbidity of erythrocyte
suspensions. An Integrating Cavity Absorption Meter, or ICAM, allows for absorption
measurements of strongly scattering samples in the visible-light region of the spectrum.
The spectrum of oxygenated hemoglobin within erythrocytes is significantly different
from the absorption spectrum of oxygenated hemoglobin in solution. Studies of the
oxygen binding to hemoglobin in erythrocytes allowed the four sequential binding
constants (Adair constants) to be determined and compared with those of hemoglobin in
solution. The Adair constants for hemoglobin in solution were found to be markedly
different from those of hemoglobin in the erythrocyte.
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Chapter 1 Introduction to Hemoglobin
1.1 The Structure of Hemoglobin
In 1959, Perutz elucidated the structure of horse hemoglobin using x-ray crystallography
techniques, and in 1963 revealed the structure of human hemoglobin.1,2 Adult
hemoglobin consists of two α-globins and two β-globins which each contain a heme
group. The heme is a porphyrin ring with an iron atom at its center. The tertiary
structure refers to a polypeptide backboard with multiple structural components, while
the quaternary structure refers to the interaction of multiple polypeptides within the same
structure. There are two conformations of the heme globins; the T-state and the R-state.
In the R-state, its oxygenated form, the heme lies in an isolated packet where it is tightly
wedged between the 16 side chains of the globin. This allows no movement of the iron
from the plane of the porphyrin ring. The iron forms 6-coordinates: four bonds to the
porphyrin ring, one bond to histidine, and the sixth to the oxygen. In the deoxygenated
T-state, the iron is in its 5 coordinated form, and the iron becomes displaced from the
porphyrin plane by 0.4 Å.3 The T-state is obstructed by the distal valine on the ligation
side, and this obstruction cannot be cleared without a change in the polypeptide structure.
Within these two different conformations, the globins determine the relationship of the
iron within the porphyrin ring. As pointed out by Perutz and others, the dominant
structural change between all four globins can be described as the α1β1 and α2β2 dimers
remaining rigid while the contacts between α1β2, α2β1, α1α2, and β1β2 move relative to each
other.2,4 During deoxygenation, the α1α2, α1β1, and α2β2 heme distances remain stationary
while the α1β1 and α2β2 act as hinges for the β1β2 heme distance increases 5Å (fig. 1.1 and
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1.2).5 The increase of the hemoglobin during the oxy-to-deoxy transition has been
termed a “molecular lung in reverse.”3

3

Figure 1.1: Molecular Lung in Reverse: Oxyhemoglobin
The α-globins are shown in transparent black, and the β-globins are shown in transparent
blue. The heme groups are represented in solid black.

Structure

Distance

Feβ1 - Feβ2

34.6 Å

Feα1 - Feβ2

25.5 Å

Feα1 - Feα2

34.7 Å

Table 1.1: Heme Iron Distances in Oxyhemoglobin
The heme iron distances remain consistent during the oxy-deoxy transition of
hemoglobin, except for the Feβ1 - Feβ2 heme distances, which increase 5 Å.
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Figure 1.2: Molecular Lung in Reverse: Deoxyhemoglobin
The α-globins are shown in transparent black, and the β-globins are shown in transparent
blue. The heme groups are represented in solid black.

Structure

Distance

Feβ1 - Feβ2

39.5 Å

Feα1 - Feβ2

24.3 Å

Feα1 - Feα2

34.2 Å

Table 1.2: Heme Iron Distances in Deoxyhemoglobin
The heme iron distances remain consistent during the oxy-deoxy transition of
hemoglobin, except for the Feβ1 - Feβ2 heme distances, which increase 5 Å.
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1.2 The History of Hemoglobin Research
Hemoglobin has been of great interest to the scientific community for the past two
hundred years. In 1825, Engelhart showed that the iron-to-protein ratio in hemoglobin
was similar across multiple species.6 In 1878, Bert gave the first crude measurements of
oxygen binding affinity.7 In 1890, Hüfner crystallized both oxyhemoglobin and
deoxyhemoglobin. When the deoxyhemoglobin crystal was exposed to oxygen, the
crystals shattered, indicating a change in the size and conformation of the hemoglobin.
Gasometric measurements in 1909 and 1922 were used by Barcroft, Haldane, and
coworkers to study the thermodynamics of hemoglobin.8,9 In 1924, Adair’s dialysis
experiments determined the molecular weight of hemoglobin.10 At the time, the
molecular weight of each globin was known to be 16,000, but the multiple of the globins
was unknown. Adair determined the four globins of hemoglobin by comparing the
molecular weight of each globin to the molecular weight of hemoglobin and the percent
iron in the protein. In 1924, the refined gasometric measurements by Adair and others
were the first attempts to determine sequential binding constants, the Adair constants, to
be determined for mammalian hemoglobins.11,12 With Adair’s work, the tetrameric
nature of hemoglobin was discovered, the molecular mass of the tetramer protein found,
and the initial groundwork for the binding constants laid.
2

(1)

3

4

1 𝐾𝐼 [𝑥]+2𝐾1 𝐾2 [𝑥] +3𝐾1 𝐾2 𝐾3 [𝑥] +4𝐾1 𝐾2 𝐾3 𝐾4 [𝑥]
𝑌̅ = 4 ∗ 1+𝐾
[𝑥]+𝐾 𝐾 [𝑥]2 +𝐾 𝐾 𝐾 [𝑥]3 +𝐾 𝐾 𝐾 𝐾 [𝑥]4
1

1 2

1 2 3

1 2 3 4

Where 𝑌̅represents the oxygen saturation of the hemoglobin and x represents the oxygen
concentration.
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Gasometric techniques can be described using a Van Slyke apparatus.13 The Van
Slyke apparatus uses a roundbottom flask filled with a solution of deoxygenated
hemoglobin. A measured amount of air with oxygen is introduced to the flask, and given
time to equilibrate. A small drop in the pressure indicated the binding of oxygen to
hemoglobin. The gasometric measurements take considerable amounts of time, and are
prone to high percent errors for the Adair constants.
Following the development of spectrophotometers, the ground work for
tonometric methods, thin-layers and automated methods were developed in which the
oxygen concentration was determined by dilution factors, calibrated flow methods, or by
oxygen electrodes.14-16 These techniques provided more precise data points, allowed
multiple measurements per sample, and required much less protein, resulting in the
replacement of the gasometric methods. Two of the methods related to our work are
included below.
1.3 Imai’s Hemoglobin Research
Imai, often considered Adair’s protégé, worked extensively on the ligand-binding
properties of hemoglobin. In the 1970s and 1980s, Imai et. al. developed a method to
study the functional properties of abnormal hemoglobin, and later improved this method
to determine the oxygen-hemoglobin equilibrium curves.17 The Imai method uses the
absorbance changes of hemoglobin at a single wavelength to determine the oxygen
saturation, and using an oxygen electrode to determine the oxygen concentration. A
solution of oxyhemoglobin is placed into a cell with magnetic stirring. The cell is placed
in the path of a double-beam spectrophotometer with the path length ranging from 5 to 25
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mm. The temperature is controlled by water circulating around the cell. A small
thermistor is placed within the cell to measure the temperature of the sample. The gas
phase above the liquid is filled and continuously replaced with argon or nitrogen, and the
dissolved oxygen is removed from the solution. The fractional saturation of the
hemoglobin is calculated via:
(2)

𝑌̅ = [𝐴𝑏𝑠(𝑥) − 𝐴𝑏𝑠(0)]/[𝐴𝑏𝑠(∞) − 𝐴𝑏𝑠(0)]

Where 𝑌̅ represents the fractional saturation of hemoglobin by oxygen, Abs(x) represents
the absorbance at a particular wavelength at a given oxygen concentration, Abs(0)
represents the absorbance at a particular wavelength where the hemoglobin is fully
deoxygenated, and Abs(∞) represents the absorbance at a particular wavelength where the
hemoglobin is fully oxygenated. Imai’s body of work resulted in a number of studies
reporting free energy changes for the successive steps of oxygenation for hemoglobin
underneath a variety of conditions.18
1.4 Parkhurst’s, Larsen’s, and Meuser’s Hemoglobin Research
Parkhurst et. al. worked to refine Imai’s method by including an enzymatic
system as well as a new method for oxygen concentration detection. This would ensure
homogenous deoxygenation throughout the sample, eliminating the lag time from the
gas-liquid equilibration from previous techniques. Parkhurst’s initial aim was to develop
an instrument that would allow rapid and continuous determinations of both fractional
saturation and oxygen depletion by spectrophotometry.19 Two enzyme systems were
used: 1) glucose oxidase with beta-D-glucose in the presence of catalase, or 2)
protocatechuate-3,4-dioxygenase in the presence of protocatechuic acid.20,21 The

8

hemoglobin sample was loaded into a stopped-flow cuvette with two syringes, which
were both filled with oxymyoglobin, bovine serum alblumin and dithiothreitol. When
glucose oxidase was used to deoxygenate the sample, the first syringe also contained
catalase and glucose, while second syringe contained glucose oxidase. When
protocatechuate-3,4-dioxygenase was used to deoxygenate the sample, the first syringe
contained protocatechuic acid and the second syringe contained protocatechuqte-3,4dioxygenase. In their initial set-up, the oxygen activity was detected using myoglobin,
and the spectrophotometer oscillated between reading the absorbance at 585.9 nm, the
isosbestic point for oxyhemoglobin and deoxyhemoglobin, and the absorbance at 590.6
nm, the isosbestic point for oxymyoglobin and deoxymyoglobin. 375 data pairs were
collected over the 25-minute duration of the hemoglobin deoxygenation, then continued
for an additional 40 minutes until the deoxygenation had reached completion and to
assure that the hemoglobin has reached a stable endpoint. During this work, Parkhurst
et. al. showed that there was a dependence of apparent fractional saturation on
wavelength, that is, fractional saturation is not exactly proportional to the absorbance
change. All of the spectrophotometric studies before Parkhurst et. al. assumed that an
absorbance change at a single wavelength can determine the four binding Adair
constants. This assumption was challenged by Rifkind and Lumry, and NasudaKouyama, but not widely accepted.22,23 Parkhurst et. al focused on using multiple
wavelengths in global fitting to determine the true Adair constants of hemoglobin binding
to oxygen.

9

Chapter 2 ICAM Design & Calibration
2.1 Introduction
In previous spectrophotometric studies of hemoglobin equilibria, the protein needed
to be in solution, and not inside of the cell. This was due to the turbidity of erythrocyte
suspensions.24 Scattering effects have always been a systematic problem in absorption
measurements.25 There have been various attempts to correct for the scattering. An
example of one of these attempts is the Integrating Cavity Absorption Meter, or ICAM.
ICAMs and their derivatives use spectrophotometers that utilize multiple passes of
light within the ICAM to increase the measured absorbance of a sample having a low
concentration of absorbing particles.26 The ICAM itself is a sphere with an entrance and
exit window, with either the inner or outer diameter of the sphere coated with a highly
diffuse reflecting white material. The walls reflect the light in a Lambertian manner until
photons are either absorbed by the sample, or leaves through either the entrance or exit
windows.27 ICAMs have been used to study pollution detection or sea particles where
the samples involved low extinction coefficients.28,29
Initial work on an ICAM began in 1953 when Walsh proposed that if light is
introduced through a small entrance window, and the surface of the sphere was
Lambertian reflective, then any point of reflectance in the ICAM will illuminate all other
surfaces of the wall equally.30 In 1970, Elterman continued the work by devising an
integrating cavity and deriving the absorbance coefficients based upon the measured
absorbances.31 The derivations were based upon the energy of light at all points of the
walls of the ICAM being equal. In 1992, Fry continued his work and continued to correct
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Elterman’s derivations.32,33 The derivations use an average pathlength in the ICAM,
derived from using the photon energy of light being equal at any one point of the ICAM.
Parkhurst derived the correct equations for both spherical and cubic ICAM to obtain
absorbance coefficients from measured absorbance of the ICAM by considering the
precise distribution of path lengths. Instead of considering the ICAM with average
energy, Parkhurst integrated over the probabilities of all pathlengths within the ICAM.
Using these unpublished results, Parkhurst found that the measured absorbance from an
ICAM would follow an exponential complement with respect to absorbance per cm in the
ICAM. The ICAM shape does matters, and the ICAM calculations could not follow a
linear relationship.
Two designs of the ICAM were developed. The equations of the first design,
denoted ICAM-milk, have been solved by Parkhurst. In ICAM-milk the sample is in
solution and does not scatter.34 The ICAM-milk will be used for non-light scattering
samples to allow detection of low absorbance samples (fig. 2.1 and 2.2) . The second
design, named ICAM+milk, cancels the Mie scattering of the erythrocytes by
overwhelming it. By adding 1% by volume of 1% fat milk to the ICAM, the caseins and
the fat globules both scatter the light more than the erythrocytes (fig. 2.3). The second
design will focus on placing samples that scatter light in the ICAM+Milk. The final
design of the ICAM is shown on figure 2.4, and details of the apparatus can be found in
appendix A. Our initial task was to calibrate both ICAMs by comparing the measured
absorbance from the ICAM to a scaled absorbance from the HPDA 8452
spectrophotometer of a sample that has no light scattering properties. Horse heart
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metmyoglobin, the oxidized form of the myoglobin, was decided to be the sample for
calibration. Metmyoglobin was chosen as the standard sample, as it absorbs across the
visible spectrum, has 4 different peaks to ensure precision on the wavelength basis, and
does not dissociate nor change its spectrum at a fixed pH.35
2.2 Materials and Methods
The initial ICAM design uses a 250 mL roundbottom flask with a sidearm, coated on
the outside with a thick, even layer of white paint. A bright pen-light was inserted onto
the open neck of the roundbottom flask in complete darkness to ensure nearly all light
was contained except for escape through the two windows. The walls were diffusely
reflecting and the light from the walls was isotropic Lambertian scattered. Two windows,
without any paint, were directly across from one another. These two windows initially
allowed the incident light to pass through the roundbottom flask. In the center top hole, a
rubber stopper was crafted. In the center of the rubber stopper a cork borer (a shaft with
a handle), which was surrounded by rubber on the top and by white waterproof paint on
the bottom (fig. 2.1). At the bottom of the shaft a deflector was attached: a thin sheet of
aluminum painted white, then lightly brushed with sandpaper. When the rubber stopper is
placed into the top of the roundbottom flask, the rubber stopper with the cork borer
attached deflects the incident light beam and causes the incident light to reflect onto the
walls of the ICAM. When the rubber stopper was put into place, the initial reflection
back through the entrance was eliminated. Effectively, an incident photon enters the
ICAM through the entrance window, becomes scattered by the baffle, and reflects
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multiple times in the ICAM until it leaves through the exit window, or it is absorbed
within the ICAM by a sample. The light leaving the exit window is completely diffuse.
The final design of the ICAM encompassed a stable temperature control,
measurement of the temperature of the solution inside of the ICAM, and measurement of
the oxygen concentration (fig 2.4). A stable temperature was maintained by pumping
water from a water bath through tygon tubing surrounding the ICAM. The tygon tubing
was wrapped around the ICAM 15 times. A hole was made in the rubber stopper and a
thermistor slid into place. Refer to figure 2.4 for the placement of these objects. The
thermistor was connected to a voltmeter, and a calibration curve of voltage versus
temperature from 15ºC to 40ºC was established. The temperature was held at room
temperature for an hour within ±0.1 degrees. The sidearm contained an YSI 5300 oxygen
electrode.36 When placed into the sidearm, an airtight seal was made with silicone
cement. The digital signal of the oxygen electrode was converted to analog using a
Sparkfun Redboard microprocessor, and relayed to a computer through a mini-usb port.
After several experiments, it was determined that a special apparatus holder
needed to be designed (appendix A). Our aims for the kinematic design were 1) to allow
an air-powered stir plate to be introduced underneath the ICAM roundbottom flask, 2)
allow adjustment of the ICAM for translation and rotation, and 3) to maintain the
reproducible placement during removal and replacement of the ICAM.37
During our experimentation, two different set-ups of the ICAM instrument were
used. Both utilized a baffle angled such that no incident light would pass through the
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ICAM without reflecting off the walls of the ICAM. This setup was called “ICAMmilk.” A second set-up of the ICAM was introduced, which included adding milk before
the zeroing and baselining processes (fig. 2.3). The 1% fat milk at 1% by volume within
the ICAM contains fat globules, roughly 3 µm in diameter at an average separation of 50
µm.38,39 The fat globules strongly scatter light.40 By introducing 1% (v/v) of 1% fat
milk, which effectively scatters the light within the ICAM, the average photon would
have a longer path length in the absence of absorption before exiting the ICAM. This
setup was called “ICAM+milk.”
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Figure 2.1: Model of the ICAM Design
A represents the entrance window for the incidence light, and B represents the exit
window for the diffuse light. In between lies a white baffle secured using a white cork
bore within a white rubber stopper. The sidearm was secured with a rubber stopper also
painted white.
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Figure 2.2: Model of the Light within the ICAM-Milk
As the collimated light from the incidence beam travels through the entrance window A,
the beam is Lambertian scattered by the baffle. After Lambertian reflection from the
walls through multiple passes, the scattered light leaves through the windows.
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Figure 2.3: Model of the Light within the ICAM+Milk
As the collimated light from the incidence beam travels through the entrance window A,
the beam is Lambertian scattered by the baffle and the milk particles. The light beam can
be reflected multiple times by the milk before being reflected by a wall. After
Lambertian reflection from the walls through multiple passes, the scattered light leaves
through the windows.
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Figure 2.4: Model of the ICAM+Milk during the Deoxygenation of Erythrocytes
A represents the entrance window. B represents the exit window. C represents the stir
bar, and D represents the baffle. E represents the overflow syringe, and F represents the
enzyme syringe with an open-close valve. G represents the oxygen electrode. H
represents the thermistor.
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Calibration curves were constructed to test the relationship between the measured
absorbance of metmyoglobin in solution in the ICAM versus the absorbance per
centimeter of metmyoglobin in the HPDA 8452. Metmyoglobin (Mb+), oxidized
myoglobin, was chosen as the correcting sample, as it absorbs across the visible
spectrum, and has 4 different absorption peaks at 500 nm, 542 nm, 575m, and 632 nm to
ensure precision on the wavelength basis.35
A solution of metmyoglobin was prepared by adding 0.010 grams of potassium
ferricyanide to 50 mL 50mM phosphate buffer, pH 8.0, with 1.2 grams of horse heart
myoglobin. The ferricyanide separated from the Mb+ with a G-25 Sephedex medium
column. The column ran for 20 minutes and the metmyoglobin was collected, and well
separated from the yellow ferricyanide. The concentration taken with the HPDA 8452
spectrophotometer, after a 1:20 dilution, using the molar extinction coefficient of 9.5*103
M-1 * cm-1 at 500 nm.41 Using the HPDA 8452 spectrophotometer, a standard
metmyoglobin spectrum from 500 nm-750nm was taken. Spectra of increasing
concentrations of metmyoglobin were taken in the ICAM. A series of measured
absorbance spectra in the ICAM+milk and the ICAM-milk were recorded and compared
compared at each wavelength to the standard scaled absorbances from the standardized
metmyoglobin spectra from the HPDA 8452. This plot was fitted well using an
exponential complement function with an automated Monte-Carlo fitting program within
Graphpad:42
(3)

𝑓(𝑥) = 𝐴 ∗ (1 − 𝑒 −𝐵∗𝑥 )
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where B represents the exponential decay parameter. This function serves as a transfer
function, allowing the measured absorbance of the ICAM to be directly compared to 1
cm pathlength HPDA spectra.
2.3 Results and Discussion
The standard spectrum of metmyoglobin (fig. 2.5) was scaled to the measured
absorbances of the metmyoglobin in the ICAM-milk and the ICAM+milk (fig. 2.6 and
2.8) and compared (fig. 2.7 and 2.9). Both of the curves were well-fitted by exponential
complements. These yielded the following transfer functions:
(4)

𝑦 = 1.423 ∗ (1 − 𝑒 −9.937∗𝑥 )

(5)

𝑦 = 0.9375 ∗ (1 − 𝑒 −40.03∗𝑥 )

for the ICAM-milk and the ICAM+milk, respectively, where x represents the absorbance
per centimeter pathlength, and y represents the measured absorbance in the ICAM. The
curve for the ICAM+milk showed much greater sensitivity for low absorbances as
compared to the ICAM-milk (fig 2.10). In both systems, Lambertian reflection occurs at
the walls of the ICAM, but the fat globules in the ICAM+milk gave much longer
pathlength for photon absorption. which explains the higher resolution at lower
concentrations.
The curve fit equations 4 and 5 represent operational equations of input-output.
The input, x, for equations 4 and 5 represents the typical absorbance per centimeter
pathlength, and the output represents the measured absorbance in the ICAM. Reversing
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equation 3 gives equation 6, which uses the measured absorbance in the ICAM as the
input, and the output is the typical absorbance per centimeter pathlength. This will yield
a typical absorbance per cm from the highly non-linear ICAM measurements.

(6)

𝑥=−

ln(

−𝑦
+1)
𝐴

𝐵

where x represents the measured absorbance in the ICAM, and A and B represent the
same parameters from equations 3, 4, and 5. The inversed transfer functions for the
ICAM-milk and the ICAM+milk are respectively:

(7)

(8)

𝑥=−
𝑥=−

ln(

−𝑦
+1)
1.423

9.937
ln(

−𝑦
+1)
0.9375

40.03

where x represents the measured absorbance in the ICAM, and y represents typical
absorbance per centimeter.
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Figure 2.5: Standard Spectrum of 22 µM Metmyoglobin
The standard spectrum of metmyoglobin in a HPDA 8452 spectrophotometer was
obtained by taking 10 scans (Δλ=2 nm) smoothed using a 9-window quadratic SavitskyGolay filter, then averaged.
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Figure 2.6: Measured Absorbances of Metmyoglobin in the ICAM-Milk.
A series of increasing concentrations of metmyoglobin in the ICAM-milk had 10 spectral
scans for each concentration smoothed using a 9-window Savitsky-Golay filter, then
averaged. The dilutions were from 31 nM, 110 nM, 270 nM, 620 nM, 1300 nM, 2400
nM, 3800 nM, 5500 nM, 9000 nM, and 16000 nM, metmyoglobin. Shown here are the
curves from 5500-16000 nM are shown.
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Figure 2.7: ICAM-Milk Transfer Function
For any particular wavelength, the measured absorbances from the ICAM were plotted on
the y-axis, whereas absorbance cm-1 data were plotted on the x-axis (see fig. 2.5 and 2.6).
The 756 data points plotted on this curve for metmyoglobin ranged from 500 to 650 nm.
The data were well-fitted by an exponential complement 𝑓(𝑥) = 𝐴 ∗ (1 − 𝑒 −𝐵∗𝑥 ), where
A equals 1.423 ± 0.036, and B equals 9.937 ± 0.376. σfit = 0.02775
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Figure 2.8: Measured Absorbances of Metmyoglobin in the ICAM+Milk
A series of increasing concentrations of metmyoglobin in the ICAM+milk had 10 spectral
scans for each concentration smoothed using a 9-window Savitsky-Golay filter, then
averaged. The dilutions were 29 nM, 88 nM, 220 nM, 510 nM, 1100 nM, 1900 nM, 3100
nM, and 4600 nM, metmyoglobin.

25

I C A M + M i lk T r a n s f e r F u n c t io n

M ea su red IC A M A b sorb an ce

1 .0

0 .8

0 .6

0 .4

0 .2

0 .0
0 .0 0

0 .0 1

0 .0 2

0 .0 3

0 .0 4

E q u i v a le n t A b s o r b a n c e p e r c m

0 .0 5

-1

Figure 2.9: ICAM+Milk Transfer Function
For any particular wavelength, the measured absorbances from the ICAM were plotted on
the y-axis, whereas absorbance cm-1 data were plotted on the x-axis (see fig. 2.7 and 2.8).
The 600 data points plotted on this curve for metmyoglobin ranged from 500 to 650 nm.
The data were well-fitted by an exponential complement 𝑓(𝑥) = 𝐴 ∗ (1 − 𝑒 −𝐵∗𝑥 ), where
A equals 0.9375 ± 0.006917, and B equals 40.03 ± 0.4584. σfit = 0.01193
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Figure 2.10: ICAM Transfer Function Comparisons
Shown are the two transfer functions from figures 2.7 and 2.9.

27

Chapter 3 Validation of the ICAM Transfer Functions
3.1 Introduction
Metmyoglobin (Mb+) was used to establish the transfer functions that related nonlinear measured absorbances from the ICAM to the absorbance per centimeter of the Mb+
solution within the ICAM. The ICAM+milk transfer function is appropriate for both
turbid and non-turbid samples in the presence of the turbid milk. As a control, the
spectrum of hemoglobin within the erythrocyte was determined independently of the
ICAM using thin-layers of packed non-scattering erythrocytes (fig 3.4) in the HPDA
8452 spectrophotometer. This technique was used by Professor Parkhurst for crystals of
erythrocytes containing carbon monoxide in 1967.43 The measured absorbance of
hemoglobin within the erythrocyte in the ICAM+milk was transformed into absorbance
per centimeter using the inverse transfer function (fig 3.5 & 3.6). The absorbances per
centimeter of the suspension of erythrocytes in the ICAM+milk were compared to the
absorbances of thin-layer of packed erythrocytes (fig. 3.7). This comparison showed that
the transfer function correctly provides the spectrum of the oxyhemoglobin within the
erythrocyte for erythrocytes in suspension in the ICAM+milk.
The ICAM-milk transfer function was meant for non-scattering samples. The
measured absorbances of hemoglobin in solution in the ICAM-milk were transformed to
absorbance per centimeter using the inverse transfer function (fig. 3.1 & 3.2). The
absorbances per centimeter of hemoglobin in solution in the ICAM were compared to
absorbances of hemoglobin in solution in the HPDA 8452 spectrophotometer (fig. 3.3).
This validates the procedure.
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3.2 Materials and Methods
Erythrocytes from Professor Parkhurst were collected into citrate tubes at the
UNL Health Center and on the same day were centrifuged at 1000xg for 3 minutes and
the supernatant replaced with 1% (w/v) sodium chloride in 50mM phosphate buffer, pH
6.8. Continued centrifugation and washing occurred until the supernatant was clear.
Hemoglobin from such samples was prepared by lysing the cells with a three times
excess of deionized H2O, centrifuging the sample at 1000xg, and collecting the
supernatant. Spectrophotometric studies of hemoglobin were at concentrations above
150 µM in heme to avoid dissociation of the tetramer.44,45 Long-term storage at 4ºC and
at -80ºC are discussed in appendix D. The suspensions of erythrocytes were centrifuged
at 2000xg for 20 minutes, and the supernatant removed. The erythrocytes (50 µL) were
placed on a microscope slide using a modified glass pipette with a larger diameter at its
tip. A cover slip was gently placed on the packed erythrocytes. Using mild pressure and
rubbing the cover slip resulted in the packed erythrocytes forming a non-scattering
erythrocyte layer between 20 µm-30 µm in thickness. The thin packed erythrocyte layer
was placed in the incident beam of the HPDA 8452, and the spectrum of hemoglobin
within the erythrocyte taken. The ICAM+milk was blanked with 270 mL of 1% (w/v)
NaCl 50mM phosphate pH 6.8 buffer with 2.7 mL of 1% milk. Afterwards, 600 µL of an
erythrocyte suspension at 10% hematocrit was added to the ICAM and the spectrum was
taken. The ICAM+milk measured absorbance was inverted to absorbance per centimeter
using the inverse transfer function. The spectrum of hemoglobin within the erythrocyte
in the thin layer and the spectrum of the ICAM+milk absorbance per centimeter were
normalized to 576 nm and compared.
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3.3 Results and Discussion
The transfer function approach used metmyoglobin for convenience. The
spectrum of oxyhemoglobin, the sample that did not scatter light, was measured using the
HPDA 8452. The measurement of oxyhemoglobin in the ICAM-milk, after inverse
transformation (eq. 7) showed no differences between the two spectra. The ICAM+milk
measured absorbance spectrum of hemoglobin within the erythrocyte were similarly
transformed to equivalent absorbance per centimeter (eq. 8) and compared to the thinlayer spectrum. There were insignificant differences between the two spectra.
Comparison of the spectra of the oxyhemoglobin within the erythrocyte to that of
hemoglobin in solution showed differences (fig. 3.8 and 3.9). The spectrum of
deoxygenated erythrocytes was compared to the literature values for deoxyhemoglobin,
and a difference appears (fig. 3.10).46 This is the first data showing the spectra of
oxyhemoglobin and deoxyhemoglobin within the erythrocyte.
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Figure 3.1: Measured Absorbance of Hemoglobin in Solution in ICAM-Milk
The measured absorbances of the hemoglobin in solution from the ICAM-milk were
transformed to standard 1 cm pathlength absorbances using the inverse of the ICAM-milk
transfer function, 𝑥 = −

−𝑦
+1)
1.423

ln(

9.937

(eq. 7).
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Figure 3.2: Absorbances of Hemoglobin in Solution in the ICAM-Milk Transformed
to Equivalent Absorbance cm-1
The measured absorbances (fig. 3.1) of the hemoglobin in solution from the ICAM-milk
were transformed to standard 1 cm pathlength absorbances using the inverse of the
ICAM-milk transfer function, 𝒙 = −

−𝒚
+𝟏)
𝟏.𝟒𝟐𝟑

𝐥𝐧(

𝟗.𝟗𝟑𝟕

(eq. 7), where y represents the

measured absorbance and x represents the equivalent absorbance cm-1.
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Figure 3.3: Comparison of Oxyhemoglobin in Solution using HPDA 8452 and
ICAM-Milk
The spectrum from figure 3.2 was scaled and compared to the spectrum of hemoglobin in
a one centimeter cuvette in the HPDA 8452. This shows that the ICAM-milk transfer
function will allow us to transfer measured ICAM absorbances to true equivalent
absorbance cm-1.

33

T h i n - L a y e r E r y t h r o c y t e S p e c t r u m in t h e H P D A 8 4 5 2
1 .2 5

A b sorb an ce cm

-1

1 .0 0

0 .7 5

0 .5 0

0 .2 5

0 .0 0
500

525

550

575

600

W a v e le n g t h ( n m )

Figure 3.4: Thin-Layer Erythrocyte Spectrum in the HPDA 8452
Packed erythrocytes with the scattering-effects eliminated were placed in the incident
beam of the HPDA 8452, and the spectrum was taken. No scattering effects were
observed since there were no refractive index differences through the illuminated area of
the sample.
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Figure 3.5: Measured Absorbances of Oxyhemoglobin within the Erythrocyte using
ICAM+Milk
The measured absorbances of the hemoglobin in solution from the ICAM+milk were
transformed to standard 1 cm pathlength absorbances using the inverse of the
ICAM+milk transfer function, 𝒙 = −

−𝒚
+𝟏)
𝟎.𝟗𝟑𝟕𝟓

𝐥𝐧(

𝟒𝟎.𝟎𝟑

(eq. 8), where y represents the

measured absorbance and x represent the equivalent absorbance cm-1.
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Figure 3.6: ICAM+Milk Measured Absorbances of Oxyhemoglobin within the
Erythrocyte Transformed to Equivalent Absorbance cm-1
The measured absorbances of the hemoglobin in solution from the ICAM+milk were
transformed to standard 1 cm pathlength absorbances using the inverse of the
−𝒚
+𝟏)
𝟎.𝟗𝟑𝟕𝟓

𝐥𝐧(

ICAM+milk transfer function, 𝒙 = −
(eq. 8), where y represents the
𝟒𝟎.𝟎𝟑
measured absorbance and x represent the equivalent absorbance cm-1.
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Figure 3.7: Spectra of Hemoglobin within the Erythrocyte in Thin-Layer vs.
ICAM+Milk
The absorbance cm-1 obtained of hemoglobin within the erythrocyte using ICAM+milk
and in the thin-layer were scaled and compared. This shows that the inverse transfer
function will transform correctly measured absorbances of turbid samples to equivalent
absorbance cm-1, correctly eliminating scattering artifacts.
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Figure 3.8: Comparison of Hemoglobin within the Erythrocyte in Thin-Layer vs.
Hemoglobin in Solution in HPDA 8452
Optical differences between oxyhemoglobin within the erythrocyte versus
oxyhemoglobin in solution are shown here, independent of the ICAM measurements.
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Figure 3.9: Comparison of Spectra of Oxyhemoglobin in Solution versus
Oxyhemoglobin within the Erythrocyte Using ICAM
The optical differences between oxyhemoglobin within the erythrocyte measured with the
ICAM+milk and oxyhemoglobin in solution are within error the same via figure 3.8
using the thin-layer method.
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Figure 3.10: Spectral Differences between Deoxygenated Hemoglobin in Solution
and within the Erythrocyte
Deoxygenated hemoglobin in erythrocytes (ICAM+milk) were compared to literature
values by normalizing both to 590 nm.46
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Chapter 4 Oxygen Binding in Intracellular Hemoglobin
4.1 Introduction
The previous chapter discussed spectral differences between hemoglobin within
erythrocytes and hemoglobin in solution in both in the oxy- and deoxy- forms. This
chapter will discuss preliminary oxygen binding data for erythrocytes using ICAM
spectrophotometry. The oxygen binding curve will be used to determine the Adair
constants and compared to data at the same wavelength for hemoglobin in solution.19
The binding constants for oxygen to hemoglobin were obtained from the fractional
saturation of hemoglobin as a function of the concentration of oxygen. The fractional
saturation of hemoglobin, 𝑌̅, is the number of bound oxygen ligands, divided by four.
The fractional saturation will be compared to the oxygen concentration.

(9)

𝑌̅ = [𝑏𝑜𝑢𝑛𝑑

[𝑏𝑜𝑢𝑛𝑑 𝑠𝑖𝑡𝑒𝑠]
𝑠𝑖𝑡𝑒𝑠]+[𝑢𝑛𝑏𝑜𝑢𝑛𝑑 𝑠𝑖𝑡𝑒𝑠]

The ligand binding curve near 𝑌̅ = 0.5 can be presented by means of the Hill plot.47

(10)

log

𝑌̅
(1−𝑌̅)

= 𝑛𝐻 ∗ log[𝑥]

Where [x] represents the concentration of the ligand and 𝑛𝐻 is the Hill number. The Hill
number provides a measure of the cooperativity of the multi-ligand binding site protein.
For 𝑛𝐻 <1, the protein exhibits negative cooperativity; and for 𝑛𝐻 >1, the protein exhibits
positive cooperativity. The Hill equation can be used to find the half-saturation of the
erythrocytes (𝑋̅), where 𝑋̅ represents the oxygen concentration when half of the oxygenbinding sites of the hemoglobin are bound with oxygen. In 1925, Adair studied oxygen
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binding to hemoglobin and found that the Hill plot for hemoglobin was not linear over
the entire concentration range of oxygen. He found that four binding constants described
the oxygenation of hemoglobin.11 Adair used the four binding constants as
phenomenological macroscopic constants, independent of any detailed model, provided
the hemoglobin tetramer does not dissociate.

(1)

2 +3𝐾 𝐾 𝐾 [𝑥]3 +4𝐾 𝐾 𝐾 𝐾 [𝑥]4
1 2 3
1 2 3 4
2 +𝐾 𝐾 𝐾 [𝑥]3 +𝐾 𝐾 𝐾 𝐾 [𝑥]4
𝐾
[𝑥]
1 2
1 2 3
1 2 3 4

1 𝐾 [𝑥]+2𝐾1 𝐾2 [𝑥]
𝑌̅ = ∗ 𝐼 [𝑥]+𝐾
4

1+𝐾1
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4.2 Materials and Methods
The ICAM+milk was used to measure the deoxygenation of hemoglobin within
the erythrocytes. The ICAM needs to maintain a stable temperature, have a way to
measure the temperature of the solution inside of the ICAM, have a system to measure
the oxygen concentration, and a system to deoxygenate the sample (fig. 4.1). The
temperature of the solution was monitored through a thermistor held in place by the
rubber stopper (fig. 2.4). The thermistor was attached to a multimeter. The thermistor
was calibrated with a calibration curve of voltage vs. temperature from 15ºC to 40ºC.
The solution temperature in the ICAM was equilibrated in lab air. The solution
temperature in the ICAM was checked over the course of one hour, with a range from 22
± 0.1 ºC. The oxygen concentration was monitored using a Yellow Springs Instruments
5300 oxygen electrode (appendix C). The correct air pressure in the lab was 698 mmHg
(appendix E). Both the temperature and the correct air pressure in the lab were used to
determine the oxygen concentration in 100% air-equilibrated solution, which was 250
µM.
The deoxygenation of the sample employed ascorbic acid in combination with Lascorbate oxidase from Cucurbita sp. obtained from Sigma-Aldrich. One unit of the
ascorbate oxidase oxidized one µmole of L-ascorbate to dehydroascorbate per minute at
pH 5.6 at 25ºC. The ascorbate oxidase from Sigma had 0.250 milligrams of ascorbate
oxidase per unit. The oxidation of ascorbic acid to dehydroascorbate occurs in a fourelectron reduction of oxygen to water without the production of free radicals. The
ascorbate oxidase contains three moles of copper. The two copper centers in ascorbate
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oxidase store reducing equivalents of from the ascorbate oxidase. This is confirmed by
EPR signals consistent with the presence of free-radicals. The two copper centers are
known to consist of a single type I copper site and a trinuclear copper, in which three
coppers are separated by 12 Å to 15 Å from the single type I copper site.48 It was found
that the two copper sites interact separately with the two substrates, and that the freeradicals were contained within the enzyme and do not produce hydrogen peroxide.49 This
removed the possibility of free-radicals forming during the deoxygenation of the
erythrocytes from enzymatic action.

The ICAM+milk had a total volume of 272 mL, consisting of 260 mL of 1%
(w/v) sodium chloride, 50 mM phosphate buffer, pH 6.8 with the addition of 10 mL of
2.6 M ascorbic acid, and 2.76 mL of 1% milk. A syringe of 25 U of ascorbic acid was
prepared in 1 mL 1% (w/v) NaCl, 50 mM phosphate buffer, pH 6.8. The tubing leading
into the ICAM had a valve for enzyme delivery (fig. 2.4). A second empty syringe was
also placed in the ICAM to capture overflow (appendix B). The dead time of enzyme
mixing was measured to one second. At time zero, the enzyme was injected, and the
valve promptly closed. The ICAM milk system scanned every nanometer from 600 to
500 nanometers with a signal averaging of 66 milliseconds. The spectral bandwidth was
set to 0.6 nanometers to ensure adequate signal-to-noise ratios. The monochromator
scanned from 600 to 500 nanometers in 12 seconds, then slewed back to 600 nanometers
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in 3 seconds. During the slew time, no data was recorded. A reading at the same
wavelength occurred every 15 seconds. The oxygen depletion was measured using the
oxygen electrode. After 8 minutes of unchanged absorbance readings, 1 mL of 0.57 M
sodium dithionite was injected to ensure complete deoxygenation.
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Figure 4.1: Block Diagram of the Instrumentation
The ICAM system employed a Cary 300 to measure spectra from light-scattering sources.
The temperature is monitored by a thermistor inside the ICAM and the signal is
monitored by a multimeter. The O2 concentration is monitored by a Yellow Springs
Instruments 5300 oxygen electrode (appendix C). Circulating water from a water bath
can be used to set the temperature.
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4.3 Results and Discussion
Preliminary workup of the oxygen binding data for erythrocytes used 576 nm
absorbances. The gradual loss of absorbance at 576 nm both from the measured ICAM
absorbance and the equivalent absorbance cm-1 is depicted in figures 4.3 and 4.4. The
voltage of the oxygen electrode (fig 4.2) was set to 5 V with air-equilibrated water,
corresponding to air-equilibrated water at a concentration of 250 µM O2 (appendix E).
The voltage vs. time was fit to a curve fit of:
(11)

𝑉𝑜𝑙𝑡𝑎𝑔𝑒 = (1.781 ∗ 10−12 𝑥 4 ) − (9.79 ∗ 10−9 𝑥 3 ) + (1.933 ∗
10−5 𝑥 2 ) − (0.01634𝑥) + 5.096

(12)

[𝑂2 ] =

𝑉𝑜𝑙𝑡𝑎𝑔𝑒
5

∗ [𝑂2 ] 𝑖𝑛 𝑎𝑖𝑟 − 𝑒𝑞𝑢𝑖𝑙𝑖𝑏𝑟𝑎𝑡𝑒𝑑 𝑤𝑎𝑡𝑒𝑟

where x represents the time in seconds. The voltage divided by 5 and multiplied by the
[O2] of air-equilibrated water obtains the concentration of oxygen dissolved in the sample
at a given point in time. The first absorbance at 576 nm started at 0 seconds and repeated
every 14.8 seconds over the course of 1600 seconds.
The Adair constants K1-K4 were determined using Gill’s ingenious equations.50
First, the absorbance changes at 576 nm in the ICAM+milk were used to determine the
franctional saturation of hemoglobin within the erythrocyte using the earlier equation:
(13)

𝑌̅ = [𝐴𝑏𝑠𝑥 − 𝐴𝑏𝑠0 ]/[𝐴𝑏𝑠∞ − 𝐴𝑏𝑠0 ]

where 𝑌̅ represents the fractional saturation of the hemoglobin within the erythrocyte,
Absx represents the equivalent absorbance per centimeter of the hemoglobin within the
erythrocyte at a given point in time, Abs0 is the equivalent absorbance per centimeter of
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fully deoxygenated hemoglobin within the erythrocyte, and Abs∞ is the equivalent
absorbance per centimeter of fully oxygenated hemoglobin within the erythrocyte. The
measured absorbance in the ICAM+milk follow a non-linear relationship with respect to
concentration. Due to this, the measured absorbances at 576 nm in the ICAM+milk were
transformed to equivalent absorbance per centimeter using the reversed transfer function
(eq. 8):

(8)

𝑥=−

ln(

−𝑦
+1)
0.9375

40.03

where y is the measured absorbance in the ICAM, and x is the equivalent absorbance per
centimeter. In this manner, the measured absorbances at 576 nm ranging from 0.453 to
0.329 were transformed to equivalent absorbance per centimeter ranging from 0.0165 to
0.0108. The equivalent absorbance at 576 nm for deoxygenated hemoglobin within the
erythrocyte, or Abs0, was determined experimentally with the addition of dithionite at
very low concentrations of oxygen. The equivalent absorbance at 576 nm for fully
oxygenated hemoglobin within the erythrocyte, or Abs∞, was found by extrapolation. In
order to determine Abs∞, a double-reciprocal plot was used plotting the inverse of F (eqs.
14-16) against the inverse of oxygen concentration, 1/[x], using the data points for the top
10% of absorbances (fig. 4.6). When a linear fit of the double-reciprocal plot is
compared to equation 16, the y-intercept is A from equation 15. When A is added to the
known Abs0, Abs∞ is obtained. When Absx, Abs0, and Abs∞ are used with equation 2, the
fractional saturation of hemoglobin with the erythrocyte can be determined. The slope of
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the double-reciprocal plot can be used to determine S2 of Gill, the upper limiting slope,
which can be used in equation 17 to determine K4.
(14)

𝐹 = 𝐴𝑏𝑠𝑥 − 𝐴𝑏𝑠0

(15)

𝐴 = 𝐴𝑏𝑠∞ − 𝐴𝑏𝑠0
1

(16)

𝐹

1

1

𝐴

𝐴𝑆2

= +

∗

1
𝑥

𝑆2 = 1/[4 ∗ 𝐾4 ]

(17)

With the fractional saturation obtained for any value of Absx, the plot of the
fractional saturation versus oxygen concentration using data from the bottom 25% of the
fractional saturation curvecan be used to determine the first two Adair constants, K1 and
K2. The fractional saturation was plotted against oxygen concentration and fitted with a
quadratic equation with the y-intercept at 0 (fig. 4.7). The fit can be used to determine the
Gill parameters S1 and C1 from equation 18,

(18)

[𝐴𝑏𝑠𝑥 −𝐴𝑏𝑠0 ]
[𝐴𝑏𝑠∞ −𝐴𝑏𝑠0 ]

= 𝑆1 𝑥 ∗ 𝐶1 𝑥 2

where S1 is a limiting slope and C1 is the curvature at the bottom of the oxygen binding
curve. The Adair constants K1 and K2 can be found directly from S1 and C1 using
equations 19 and 20.
(19)
(20)

𝑆1 = 𝐾1 /4
𝐶1 = [2𝐾1 𝐾2 − 𝐾1 2 ]/4

The next two parameters, the Hill number, 𝑛𝐻 and the concentration of oxygen at halfsaturation, or 𝑋̅, were determined using the Hill plot (fig. 4.5). The Adair constant K3 was
determined through a univariate fit of equation 1 using Graphpad (fig. 4.8). Figure 4.8
shows the Adair constant curve fit versus experimental data.
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Abs0
Abs∞
K4
K1
K2
𝑋̅
𝑛𝐻
K3

Hemoglobin within Erythrocytes
0.0107
0.0167 ± 0.00013
2.7306 ± 0.3684
0.0353 ± 0.00638
0.0878 ± 0.0144623
23.28 ± 4.6µM
2.036 ± 0.1155
0.000448 ± 0.0000378

Table 3.1: Parameters for Oxygen Binding to Hemoglobin within the Erythrocyte
Determined at 576 nm
Adair constants with the two parameters used for the oxygen binding curve fit are
compared to literature values.
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The preliminary data show weaker oxygen binding of oxygen-to-hemoglobin
within the erythrocyte at lower oxygen concentrations when compared to hemoglobin in
solution. This corresponds to more efficient delivery of oxygen to tissues under high
oxygen demand. Our data also show the oxygen binding at higher oxygen concentration
is tighter than hemoglobin in solution, for a more efficient uptake of oxygen for the
erythrocytes in the lungs. During the spectrophotometry studies of hemoglobin, the heme
concentration was kept above 150 µM to ensure the α2β2 tetramer does not dissociate to
αβ dimers.45 The intracellular hemoglobin concentration inside human erythrocytes is 20
mM, and the concentration within the crystal is 40 mM. The R/T conformational change
cannot be accommodated within the same crystal lattice. Inter-tetramer distances within
the erythrocyte are only 25% longer than in the crystal, perhaps the minimum needed for
the R/T conformational change. There are clear functional differences in the hemoglobin
tetramer within the erythrocyte versus in solution that correlate with the difference in
packing.
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Figure 4.2: Oxygen Electrode Measurements
The function 𝒇(𝒙) = 𝑨𝒙𝟒 + 𝑩𝒙𝟑 + 𝑪𝒙𝟐 + 𝑫𝒙 + 𝑬 was used to fit the 1529 data points
of voltage over time during the deoxygenation of erythrocytes. The curve fit uses A =
1.781 * 10-12; B = -9.79 * 10-9; C =1.933 * 10-5; and D= -0.01634; and E equals 5.096,
with σfit = 0.0117.
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Figure 4.3: Measured ICAM Absorbances during Continuous Deoxygenation of
Erythrocytes within ICAM+Milk
Every 5th scan for the ICAM is shown for clarity. The measured ICAM absorbances
were transferred to equivalent absorbance cm-1 using the reversed transfer function (eq. 8)
for ICAM+milk (fig. 4.4).
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Figure 4.4: Equivalent Absorbances during Continuous Deoxygenation of
Erythrocytes within the ICAM+Milk
Every 20th scan for the ICAM is shown for clarity. The measured absorbances (fig. 4.3)
were transformed with equation 8 to calculate the equivalent absorbance cm-1 at 576 nm.
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Figure 4.5: Hill Plot of Oxygen Binding to Hemoglobin within the Erthryocyte
The Hill equation was fitted to the data at half-saturation from 𝑌̅ at 0.821 to 0.218 with a
linear fit 𝑓(𝑥) = 𝑚𝑥 + 𝑏, where x is the log of oxygen concentration, m equals 2.071 ±
0.1155, and b equals -2.831 ± 0.1632. The Hill coefficient, nH was 2.071 ± 0.1155 by
least-square, and the half-saturation 𝑋̅ was 23.2 ± 4.6 µM. σfit = 0.0761
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Figure 4.6: Fitting the Top 10% Portion of the Oxygen Binding Curve
The top 27 fractional saturation data points were used to find both Abs∞ and S2 by a
double reciprocal plot of 1/F vs. 1/x, where 𝑭 = 𝑨𝒃𝒔𝒙 − 𝑨𝒃𝒔𝟎 and x is the oxygen
𝟏
𝟏
𝟏
𝟏
concentration in µM. A linear fit with 𝑭 = 𝑨 + 𝑨𝑺 ∗ 𝑿 gives the values of Abs∞ and S2
𝟐

using equations 13-15. The linear fit of 𝒇(𝒙) = 𝒎𝒙 + 𝒃 gave m = 1845 ± 249.2, and b =
168.7 ± 3.703. Calculations using equations 14-17 gave Abs∞ = 0.0167 ± 0.00013. The
Gill parameter S2 could be determined using the linear fit, and equation 17 with S2
determined K4 = 2.7306 ± 0.3684. σfit = 7.909
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Figure 4.7: Fitting the Low Portion of the Oxygen Binding Curve
Determining S1 and C1 from the curve fit 𝒇(𝒙) = 𝑺𝟏 𝒙 + 𝑪𝟏 𝒙𝟐 . S1 was equal to 0.008818 ±
0.01601, while C1 was equal to 0.001238 ± 0.0002044. Using the Gill equations, these
can be used to calculate K1 and K2. σfit = 0.02202
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Figure 4.8: K3 Determination through Univariate Fitting
This figure shows the calculated oxygen binding curve using the Adair constants with
univariate fitting to determine K3 = 0.000448 ± 0.0000378, with σfit = 0.04933.
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Figure 4.9: Oxygen Binding of Human Hemoglobin in Solution vs. within the
Erythrocyte
The oxygen binding curve of human hemoglobin within the erythrocyte was determined
at pH 6.8 and 22ºC, and compared to literature values.
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Chapter 5 Future Directions and Conclusions
Marked functional differences between the hemoglobin in solution and the
hemoglobin within the erythrocyte have been shown and quantified. It is now important
to determine the binding free energies and enthalpies at the normal body temperature of
37ºC. Continued studies of adult human hemoglobin ranging over pH and temperature
should also be done with Parkhurst’s multiple wavelength global analysis. This will give
the complete thermodynamic description of oxygen binding in normal human
hemoglobin within the erythrocyte.
Thermodynamic studies of disease state erythrocytes, such as sickle-cell anemia
(HbS), are expected to give new insight into the disease states of hemoglobin. HbS
hemoglobin showed high cooperativity with unusually large concentration-dependent Hill
coefficients.51 However, this conclusion has been questioned.52 The thermodynamics of
oxygen binding with hemoglobin S are highly concentration dependent. The
spectrophotometry of hemoglobin S required polymers and linkage theory to ensure the
dimerization of hemoglobin does not occur in solution while the hemoglobin S is in close
interaction with other tetramers. Studies of HbS within the erythrocyte would give clarity
of the concentration-dependent thermodynamics of sickle-cell anemia.
Different iterations of the ICAM could also be explored. Parkhurst’s derivations
of the ICAM-milk showed the curve fit to be an exponential complement, which were
shown in chapter 1. The derivations for a cube have also been deduced, and for a cuvette
with reflective walls designed by 3D printing.
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Appendix A Apparatus Holder Design
A.I Introduction
Early in the studies with the ICAM roundbottom flask, the ICAM was housed in a
very simple apparatus in the sample chamber. That apparatus showed noticeable
absorbance changes over time due to a shift of the ICAM during operation. Due to these
flaws, a new apparatus was designed to eliminate absorbance drift.
A.II Materials and Methods
The initial design of the ICAM system utilized a 250 mL roundbottom flask
coated on its outer surface with a flat white paint. A pneumatically driven magnetic stir
plate was set into the instrument sample chamber with a cork roundbottom flask holder to
hold the ICAM when in operation. The incident light traveled through the ICAM and
was scattered, while the reference beam in the Cary 300 was kept in the same logarithmic
range as the incidence beam by use of a neutral density filter.
To determine the instrument noise with this setup, the ICAM was zeroed and
blanked with 270 mL 50 mM phosphate buffer, pH 6.8, with the baffle in place.
Afterwards, 1000 µL of 1 mM hemoglobin solution was added to the ICAM, and 1000
scans were run over the course of 150 minutes. Figure A.1 shows 10 spectra, each
representative of 100 scans smoothed by a 9 point quadratic Savitzky-Golay filter, and
averaged together. Unfortunately, there was a loss of absorbance due to movement of the
ICAM in the initial apparatus. It was decided a new ICAM apparatus holder needed to be
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designed. The new apparatus holder was designed out of aluminum using kinematic
design principles.53 The new design was tested to determine if the absorbance reading at
576 nm was stable over the course of 1000 scans using 270 mL 50 mM phosphate buffer,
pH 6.8 with 1000 µL 652 mM human hemoglobin, and the ICAM did not move during
operation.
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A.III Results and Discussion
The measured absorbances in the ICAM-milk before the new apparatus holder
was built showed a steady decrease in absorbance over the course of the 150 minutes due
to ICAM slippage (fig. A.1). The instrument was unstable, constantly shifting on top of
the cork holder. When the new ICAM apparatus holder was introduced, there was no
change in absorbance over the course of the 150 minutes (fig. A.2).
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Figure A.1: Measured Absorbance in ICAM-Milk Due to ICAM Slippage in the
Initial Version of the ICAM
A loss of absorbance at 576 nm was noticed when 1000 scans of hemoglobin were each 9
point quadratic Savitzky-Golay filtered, then averaged into groups of 100. This steady
loss was due to the progressive movement of the ICAM.
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Figure A.2: Stability of the New ICAM Holder
The ICAM was placed in the new holder and its change of absorbance over time was test
using 270 mL 50 mM phosphate buffer, pH 6.8 with 1 mL of 652 mM hemoglobin. This
showed no change over time.
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Appendix B Settings of the ICAM
During the final experiments, the standard procedure was to run the experiment
from 600 nm to 500 nm unless otherwise stated. The stepper motor in the Cary 300
stepped every 1 nm (λ). The minimum time for an absorbance measurement was set by
the speed of the double choppers. The time for an absorbance measurement at each
wavelength was set to 66 milliseconds. The Cary 300 stepper motor would scan from
600 nm to 500 nm (unless otherwise stated) in the course of 12 seconds. The stepper
motor would slew from 500 nm back to 600 nm with no absorbance measurements taken
during this time. The slewing took 2.8 seconds. The timings of the stepper motor were
determined through direct observation from numerous consecutive runs.
The stirring speed was controlled by the pressure of the air flowing through the
pneumatically driven magnetic stir plate. The highest pressure allowed without any
wobbling was 18 PSI. In order to ensure consistent stir speeds, the revolutions per
second in the ICAM were determined by holding a stethoscope to the neck of the ICAM
and attaching the earpiece to a microphone recording the sound. A freeware Winscope
program developed by Andy Collinson sampled input waveforms from a computer’s
microphone measurements.54 The sample was stirred by a Teflon coated magnet at a
constant speed of 2.7 revolutions per second to ensure a homogenous solution within the
ICAM during its operation (fig. B.1). The stirring dead time was determined by adding a
sample of metmyoglobin into the ICAM+milk via a syringe. The metmyoglobin
spectrum was constant within 1.1 seconds (fig. B.2). Due to the short dead time, no
corrections for the stirring dead time were necessary.
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Figure B.1: Oscilloscope Microphone Measurements at 18 PSI
Each grouping represents a half-turn of the stir bar in the ICAM at 18 PSI. The distance
between one set of peaks and the other was determined to be 0.185 seconds per half-turn,
or 2.7 revolutions per second.
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Figure B.2: Stirring Dead Time of ICAM+Milk
The stirring dead time was determined by using a solution of 462 µM metmyoglobin in
50 mM sodium phosphate, pH 8.0. The ICAM was blanked with 268.2 mL 50 mM
sodium phosphate, pH 8.0 with 2.7 mL 1% milk. 1.7 mL of the metmyoglobin solution
was injected into the ICAM+milk and the absorbance change at 500 nm recorded over
time.
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Appendix C Automated Oxygen Electrode

The oxygen concentration in the ICAM during the deoxygenation process was
measured through a YSI 5300 oxygen electrode. The YSI oxygen electrode was a Clark
electrode, which reduced oxygen and required stirring to maintain equilibrium with the
electrode environment. The Clark oxygen electrode uses platinum-silver electrodes
surrounded by potassium chloride and the electrode chamber separated from the reaction
chamber by a Teflon membrane. The Teflon membrane was permeable to dissolved
oxygen, and the electrodes generated a reaction with the oxygen being the limiting
reagent. The reaction is O2 + 4 e- + H2O  4 OH-. The instrument was self-calibrating
with analog measurements shown on the instrument’s interface in terms of percentages.
The instrument was set to 100% using air-equilibrated water. The calculation of the
oxygen concentration for air-equilibrated water is in appendix V. The analog signal was
converted to digital in order to ensure fast, precise oxygen concentration measurements.
The conversion occurred using a Sparkfun Redboard microprocessor. A wire ran from
the differential port on the YSI 5300 to the A0 analog port on the Redboard, while another
wire ran from the grounding port on the YSI 5300 to the grounding port on the Redboard.
The Redboard was connected to a computer using a mini-USB port on the Redboard to a
USB port on the computer. The Redboard was programmed using Arduino, a freeware
program provided by Sparkfun (see fig. C.1).
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/*
Analog-to-Digital
Reads an analog input on pin 0, converts it
to voltage, and prints the result to the serial
monitor.
*/
// the setup routine runs once when you
press reset:
void setup() {
// initialize serial communication at 9600
bits per second:
Serial.begin(9600);
}
// the loop routine runs over and over
void loop() {
// read input on analog pin 0:
int sensorValue = analogRead(A0);
// Convert the analog reading (which goes
from 0 - 1023) to a voltage (0 - 5V):
float voltage = sensorValue * (5.0 / 1023.0);
// print out:
Serial.println(voltage);
delay(1000);
}
Figure C.1: Arduino Program for the Oxygen Electrode
This program was programmed into the Redboard microprocessor. The microprocessor
took the analog signal as a scale from 0-1023 bits, and converted it to digital signal as
voltage (0-5V). The voltage could be transformed into percent relative oxygen by
dividing by 5.
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Appendix D Erythrocyte Storage, Retrieval, and Survival
D.I Introduction
Blood transfusion was the most important medical advance of World War I with
the development of a citrate-glucose solution used to store blood.55 At the time, however,
it was not clear how to store frozen blood and later recover it. In the 1950s, Lovelock
stated that the damage to red blood cells during the freezing and thawing process was due
to the osmotic stress.56 Shortly after, Smith, working with Polge, discovered glycerol as
the first practical cryoprotectant molecule, and used it to cryopreserve, thaw, and
subsequently wash the red blood cells free of cryoprotectants.57,58 It was thought that the
storage of red blood cells would eliminate the problems associated with erythrocyte
suspensions in transfusion: seasonal shortages, rare blood types, and natural disasters.
Two main groups of cryoprotectants have been developed, classified as “penetrating” and
“non-penetrating.”59,60 The former, such as glycerol, invade the cell and change the
osmotic equilibrium during freezing. In this way, the volume reduction due to
intracellular ice formation is reduced. The second group of cryoprotectants form a shell
around the erythrocyte in a process called vitrification, and in this way, protect the red
blood cells from osmotic damage. During the freeze-thaw-wash (FTW) processing of red
blood cells, there are two main problems. One of them is the initial lysis of red blood
cells, and the second is the post-thawing survivability of the red blood cells. If enough
osmotic damage occurs, or if the cell function is limited after post-FTW, or if the cell
cannot maintain integrity in the thawing solution, then hemolysis will happen rapidly
over the course of a few days. Our goal post-FTW is focused on the latter. We make the
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assumption that post-FTW survivability indicates the RBC are more physiologically
relevant.
The goal of post-FTW survivability is based upon post 24-hour transfusion
survival rates. National Academy of Science NRC has arbitrarily established a survival
of 70% in 24 hours post-transfusion as the acceptable level for the viability of preserved
erythrocytes. For our work, we arbitrarily set our goal as less than 1% per day. This
would ensure a sample that would remain relatively stable over the course of 2-3 weeks.
We found that using 40% (v/v) glycerol as a cryoprotectant and using AS-3 storage
buffer (100 mL H2O, 1.10g of dextrose monohydrate, 0.558g of sodium citrate dihydrate,
0.276 g of monobasic sodium phosphate monohydrate, 0.42 g of citric acid monohydrate,
and 0.030 g of adenine) offered our samples three-weeks of adequate post freeze-thawwash survival at 4ºC.61,62
D.II Materials and Methods
Initially, our work began with Flegel’s work at the NIH, who focused on using
polyvinyl pyrrolidone (PVP) as a non-invasive cryoprotectant (16). Human blood from
KH or LJP was collected into concentrated ethylenediaminetetraacetic acid, and stored at
4ºC. The samples were centrifuged at 1000xg for 5 minutes to isolate the red blood cells.
The packed RBC samples had the supernatant removed, and the lost volume replaced
with 1% w/v NaCl, 50 mM sodium phosphate buffer pH 6.8 (PBS buffer). This process
was repeated until the supernatant was clear. The packed red blood cells were
cryoprotected in one of two ways: fast-freezing through non-invasive cryoprotectants,
and slow-freezing through invasive cryoprotectants.
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With the non-invasive cryoprotectants, one volume of packed erythrocytes was
introduced into one volume of PVP freezing solution (27mL of 30% w/v bovine serum
albumin with 23% (v/v PVP in deionized H2O). The mixture was allowed to equilibrate
for 1 hour. Afterwards, the mixture was pipetted dropwise into a liquid nitrogen-filled
Dewar flask. These droplets were collected with a metal spatula, and placed into a
cryovial tube with the top punctured several times. Both the cryovial tubes and the metal
spatula were chilled with liquid nitrogen beforehand to ensure the droplets didn’t thaw
and stick on contact. Afterwards, the cryovial tubes were placed into the -80ºC freezer
until thawed.
During the thawing process, the desired amounts of droplets (around 80-160 µL
each) were placed into 1.5 mL of PBS buffer at 37ºC with gentle shaking. After
complete suspension, the sample was washed with storage buffer at 3 fold-excess until no
hemolysis occurred (around 2-3 washes). This lowered the PVP left in solution to
approximately 0.0001 M. Afterwards, the red blood cells were resuspended, aliquoted
into individual-use Eppendorf tubes and placed into 4ºC storage until use. The two
storage buffers used were 1% PBS buffer and AS-3 solution.
Valeri’s work with the Naval Blood Research Laboratory focused on invasive
cryoprotectants.61,62 Two volumes of a glycerol freezing solution (50% w/v glycerol, 1%
w/v 2-hydroxy-propanoic acid, 1% w/v KCl, 50 mM sodium phosphate buffer, pH 6.8)
were added for every volume of packed red blood cells. The mixture was allowed to
equilibrate for 1 hour. Afterwards, the mixture was aliquoted into cryovials, and the
temperature was lowered at 1ºC/min by insulating the test tubes in a room-temperature
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Styrofoam box, which was placed into the freezer and the temperature checked every
hour until -80ºC was reached.
Two different thawing procedures were used to remove the intracellular glycerol.
The frozen glycerolized samples were warmed to 37ºC. Afterwards, the samples were
centrifuged at 1000xg and the supernatant removed. 1 volume of 12% PBS buffer was
added dropwise to 3 volumes of the thawed RBC sample with gentle mixing, and
equilibrated at room temperature for 3 minutes. Afterwards, 3 volumes of 0.2% dextrose
(w/v), 0.9% saline (w/v) was added dropwise with gentle shaking, then left to equilibrate
for 3 minutes, and this process was repeated 4 times. At this point, the sample was
centrifuged for 3 minutes at 1000xg, and then an eighth of the total volume was aspirated,
replaced with storage buffer, then the packed RBC were resuspended. This process was
repeated 8 times, with the following volumes aspirated and replaced: 1/8th, 1/4th, 3/8th, ½,
and finally 4/5th. Afterwards, the RBC samples were aliquoted into one-use Eppendorf
tubes and placed into the 4ºC refrigerator. The two storage buffers used were 1% PBS
buffer and AS-3 solution.
D.III Results and Discussion
Hemolysis rates were measured by removing the sample from the 4ºC
refridgerator and centrifuging the sample for 3 minutes at 1000xg. The supernatant was
removed and placed in a pre-tared Eppendorf tube. The packed erythrocytes were
resuspended using storage buffer. Both samples were massed, and the density assumed
to be 1g/mL. Both of these solutions had 10-100 µL removed and placed into 2 mL
deionized H2O. The absorbances at 578 nm for both of these diluted solutions were
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measured and their final concentrations measured. The total heme lysed versus the total
heme in cells give us the total hemolysis and total survival.
We assume that higher post-FTW survival indicates the RBC are more likely to
be physiologically relevant. Based on our results, we decided that using Valeri’s
methods with glycerol and AS-3 solutions would be most effective as compared to
Flegel’s method with polyvinylpyrrolidone. Personal contact with Flegel and Valeri,
revealed that their aims were different. Valeri was focused on survival rates post FTW at
4ºC due to his career’s work with the US naval research laboratories. He was focused on
keeping rare blood types viable on warships for long periods of time. Flegel, on the other
hand, focused his work on laboratories using the thawed red blood cells on that given
day, and focused on quick and efficient methods to thaw erythrocytes for a single day’s
use.
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Figure D.1: Lysis of Erythrocytes During 4 Degrees Celsius Storage in AS-3 PostGlycerol Freeze-Thaw-Wash
Valeri’s methods of erythrocyte storage and retrieval using glycerol as a cryoprotectant
for the erythrocytes at -80ºC followed by AS-3 solution in the erythrocyte suspension at
4ºC proved adequate for three weeks.

76

L y s is o f E r y th r o c y te s D u r in g 4 D e g r e e s C e ls iu s S to r a g e in P B S
a fte r P o ly v in y l P y r r o lid o n e -8 0  C S to r a g e

% T o ta l L y s is

80

60

40

20

0
0

2

4

6

8

10

12

D ays

Figure D.2: Lysis of Erythrocytes During 4 Degrees Celsius Storage in PBS after
Post-Polyvinyl Pyrrolidone -80ºC Storage
Ten days after retrieval from -80ºC storage, 60% of the erythrocytes had lysed in 4ºC
PBS buffer.
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Appendix E Dissolved Oxygen Calculations
In order to determine the concentration of air-equilibrated water, the true air
pressure and temperature were recorded. The temperature of the lab was recorded with a
thermometer. The air pressure and humidity were given by KLNK airport. The lab was
determined to be 75 feet above KLNK airport. The true air pressure was given
determined by:
(21)

26 𝑚𝑚𝐻𝑔

𝐿𝑎𝑏 𝐴𝑖𝑟 𝑃𝑟𝑒𝑠𝑠𝑢𝑟𝑒 = [𝐾𝐿𝑁𝐾 + (75 𝑓𝑒𝑒𝑡 ∗ 1000 𝑓𝑒𝑒𝑡 𝑎𝑏𝑜𝑣𝑒 𝑠𝑒𝑎 𝑙𝑒𝑣𝑒𝑙)]

The oxygen activity can be determined using the gas solubility tables.

(22)

𝑋𝐴 =

𝛼 𝑇 (0.20946)
𝑅(273.18)

∗

𝑃𝑏 −𝑃𝑇 𝐻
760 𝑚𝑚𝐻𝑔/𝐴𝑡𝑚

Where: 𝛼 𝑇 = the volume of oxygen in liters absorbed by one volume of water when the
pressure of the gas itself amounts to 760 mm.63
R = 0.082054 liter atm. deg.-1 mol-1
Pb = ambient lab air pressure in mmHg
PT = ambient pressure of water at a temperature read from the table
H = ambient %relative humidity divided by 100.
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